диссертации / 116

/ Kruzel M.L., Harari Y., Mailman D., Actor J.K., Zimecki M. // Clin Exp

Immunol. - 2002. - Vol. 130. - P.25–31.

107.Lee, N.K. Endocrine regulation of energy metabolism by the skeleton. / Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., Dacquin R., Mee P.J., McKee M.D., Jung D.Y., Zhang Z., Kim J.K., Mauvais-Jarvis F., Ducy P., Karsenty G. // Cell. - 2007. - Vol.130. - №3. - Р 456–469.

108.Lindsay, R. Osteoporosis. A Guide to Diagnosis, Prevention, and Treatment / Lindsay R. // Raven Press (New York). - 1992. - P.1-39.

109.Liu, C.J. ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein/ C.J.Liu, W.Kong, K.Ilalov, et al.// FASEB J. - 2006. - Vol. 20. - №.7. - Р. 988–990.

110.Liu, C.J. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein/ Liu C.J.// J Biol Chem. - 2006. - Vol. 281. - № 23. Р. - 15800–

15808.

111.Loeuille, D. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. [Text] / Loeuille D., Chary-Valckenaere I., Champigneulle J., Rat A.C., Toussaint F., Pinzano-Watrin A., Goebel J.C., Mainard D., Blum A., Pourel J., Netter P. // Gillet P.Arthritis Rheum. - 2005. - Vol. 52. P. 3492–3501.

112.Lorget, F. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. [Text] / Lorget F., Clough J., Oliveira M., Daury M.C., Sabokbar A. Offord E. // Biochem. Biophys. Res. Commun. - 2002. - Vol. 296. -

P.261–266)

113.Luan, Y. Inhibition of ADAMTS-7 and ADAMTS-12 Degradation of Cartilage Oligomeric Matrix Protein by Alpha-2-Macroglobulin [Text] / Y. Luan,

L.Kong, D. R. Howell // Osteoarthritis Cartilage. - 2008. - Vol. 16. - № 11. -

Р.1413–1420.

114. Maneva, A.I. Effect of bovine milk antigens and egg lysozyme on the binding of 59. Fe-Lactoferrin to platelet plasma membranes II Int / A.I.Maneva, B.M.Taleva, V.V. Manev // - J. - Biochem. -1993. - Dec. -Vol. 25. - N 12. - P. 1785-1790.

110

115.Mautalen, CA. Calcium metabolism and its regulating hormones in patients with leprosy.[Text] /Mautalen CA, Vaquero NL, Zeni SN,/ Int J Lepr Other Mycobact Dis. - 1994. - Vol.62. - №4. - Р. 580-585.

116.Marriott I. Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.[Text] / Immunol Res. - 2004. - Vol. 14. - P.291–308.

117.Melching L.I. The cleavage of biglycan by aggrecanases. [Text] / L.I.Melching, W.D. Fisher, E.R. Lee // Osteoarthritis Cartilage. 2006. - Vol. 14. -

№11. - Р.1147–1154.

118.Mincheva-Nilsson L. Activated human gamma delta T lymphocytes express functional lactoferrin receptors. [Text] / Mincheva-Nilsson L., Hammarstrom S., Hammarstrom M.L., Scand J Immunol. 1997. - Vol. - 46 P. 609–618.

119.Mehta L, Dorvadi MH, Damavandi NM. Alkaline phosphatase activity in

peripheral nerves and endothelial cell cultures in leprosy [Text] /Mehta L, Dorvadi MH, Damavandi NM / Indian J Lepr 1987. - Vol. 59. - №2. - Р.171177.

120.Miyauchi H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain.[Text] / Miyauchi H., Hashimoto S., Nakajima M., Shinoda I., Fukuwatari Y., Hayasawa H. // Cell Immunol. - 1998. - Vol. - 187. P34–37.

121.Miyauchi, J. Immunocytochemical localisation of lactoferrin in human neutrophils. An ultrastructural and morphometrical study/ J.Miyauchi, J.Watanabe // Cell. - Tissue. - Res. - 1987. - Vol. 247. -P. 249-258.

122.Muruganand D. Mycobacterium leprae infection and serum lactoferrin levels / Muruganand D., Ebenezer D. // Lepr. Rev. – 2004. – Vol.75,─ Р. 282288.

123.Ning, R.D. The effect of Staphylococcus aureus on apoptosis of cultured human osteoblasts.[Text] / Ning R.D., Zhang X.L., Li Q.T., Guo X.K. // Orthop Surg. - 2011. - Vol.14. - 199–204.

111

124.Ochoa, T.J. Lactoferrin blocks the initial host cell attachment mechanism of Enteropathogenic E. coli (EPEC) / Ochoa T.J., Noguera-Obenza M., Cleary T.G. // Adv Exp Med Biol. - 2004. - Vol. 554. - P.463–466.

125.Okamoto, T. Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils. / Okamoto T., Tanida T., Wei B., Ueta E., Yamamoto T., Osaki T. // Clin Diagn Lab Immunol. - 2004. - Vol. 11.- P 1111–1119.

126.Oseas, R. Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. / Oseas R., Yang H.H., Baehner R.L., Boxer L.A. // Blood. - 1981. - Vol. 57. - P. 939–945.

127.Oury, F. Endocrine Regulation of Male Fertility by the Skeleton./ Oury F., Sumara G., Sumara O., Ferron M., Chang H., Smith C.E., Hermo L., Suarez S., Roth B.L., Ducy P., Karsenty G. // Cell. - 2011. Vol. 144. - №5. - Р. 796–809.

128.Parkash, O. Serum lactoferrin in lepromatous leprosi patients / Parkash O., Girdhar B.C., Sengupta U. // Lepr Rev - 1993. - Vol. 64 - P. 295-301.

129.Percival, S.L. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms / Percival S.L., Hill K.E., Malic S., Thomas D.W., Williams D.W. // Wound Repair Regen. - 2011. - Vol. 14. - P.1–9.

130.Pi M. GPRC6A Mediates Responses to Osteocalcin in beta-Cells In Vitro and Pancreas In Vivo. /Pi M., Wu Y., Quarles L.D. // J Bone Miner Res.- 2011

131.Puddu, P. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. / Puddu P., Carollo M.G., Belardelli F., Valenti P., Gessani S.J. // Leukoc Biol. - 2007. - Vol. 82. - P.347–353.

132.Razzaque, M.S. Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism? / Razzaque M.S. // Nephrol Dial Transplant. - 2011. - Vol.26.

№1. - Р.42–45.

133. Rani, S. Periostin-like-factor and Periostin in an animal model of workrelated musculoskeletal disorder. / Rani S., Barbe M.F., Barr A.E., Litvin J. // Bone. - 2009. Vol. 44. - P.502–512.

112

134.Rani, S. Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping. [Text] / Rani S., Barbe M.F., Barr A.E., Litvin J.

//J Cell Physiol. - 2010. - Vol. 225. - №1. - Р. 152–167.

135.Reghunathan, R. Expression profi le of immune responsegenes in patients with Severe Acute Respiratory Syndrome. / Reghunathan R., Jayapal M., Hsu L. Y., Chng H. H., Tai D., Leung B. P. // BMC Immunol. 2005. - Vol 6. P. - 2.

136.Ritchlin C. Patterns of cytokine production in psoriatic synovium/ Ritchlin C., Yaas-Smith S.A., Hicks D. //J.Rheumatal.- 1998.- Vol.25. - № 8. - Р. 15441552.

137.Ringe, J.D. Generalisierte osteoporose bei chronischer polyarthritis / Ringe J.D. // Z.Rheum. - 1996 - Vol.55. - № 3. - Р. 149-157.

138.Roemer, F. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. / Roemer F., Guermazi A., Felson D., Niu J., Nevitt M., Crema M.

//Ann Rheum. - 2011. - Vol. 70. - P - 1804–1809.

139.Roseanu, A. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: the role of cell surface sulphated molecules. / Roseanu A., Chelu F., Trif M., Motas C., Brock J.H. // Biochim Biophys Acta.- 2000. - Vol. 1475. - P.35–38.

140.Rosenberg, G.A. Matrix metalloproteinases in neuroinflammation./ G.A. Rosenberg // Glia. - 2002. - Vol. 39. - №3. - Р.279–291.

141.Salzet, M. Leech thrombin inhibitors.// Salzet M. - Curr. Pharm. Des. - 2002. - Vol.8. - №7. - P. 493–503.

142.Smiley, S. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. / Smiley S., King J., Hancock W.J // Immunol. - 2001. - Vol.167. - P. 2887–2894.

143.Sohn, D.H. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor / D.H.Sohn, J.Sokolove, O.Sharpe, et al. // Arthritis. Res. Ther.- 2012. - Vol. 14 . - №1. Р.7.

144.Stahel, P. Role of biological modifiers regulating the immune response after trauma / Stahel P., Smith W., Moore E. - 2007. - Vol.38. - P. 1409–1422.

113

145. Stanton, H. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro / H. Stanton, F.M. Rogerson, C.J. East // Nature. - 2005. - Vol. 434. -

№7033. - Р.648–652.

146.Suzuki, Y.A. Mammalian lactoferrin receptors: structure and function. / Suzuki Y.A., Lopez V., Lonnerdal B. - Cell Mol Life Sci. - 2005. - Vol. 62. - P. 2560–2575.

147.Tchetverikov, I. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis / Tchetverikov I., L. R. Lard, J. DeGroot, N. Verzijl, J. M. TeKoppele, F. C. Breedveld, T. W., J. Huizinga, R. Hanemaaijer // Ann Rheum Dis. - 2003. - Vol. 62. - P. 1094–1099

148.Tortorella, M.D. Alpha2-macroglobulin is a novel substrate for ADAMTS- 4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes / M.D. Tortorella, E.C. Arner, R. Hills // J Biol Chem. - 2004. - Vol. 279. - № 17. -

Р.17554–1756.

149.Trif, M. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases / Trif M., Guillen C., Vaughan D.M.// Exp Biol Med. - 2001. - Vol. 226. - P.559–564.

150.Valenti, P. Lactoferrin: an important host defence against microbial and viral attack / Valenti P., Antonini G. // Cell. Mol. Life. Sci. - 2005. - Vol. 62. - P. 2576–2587.

151.Vankemmelbeke, M.N. Expression and activity of ADAMTS-5 in synovium. / M.N. Vankemmelbeke, I. Holen, A.G. Wilson //Eur J Biochem. - 2001. - Vol.268. - №.5. - Р.1259–12688.

152.Yeap, B.B.Norman PE. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. / B.B.Yeap, S.A.Chubb, L.Flicker et al. // Eur J Endocrinol. - 2010. - Vol. 163. - №2. - Р.265–272.

153.Yamauchi, M. Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women. / M.Yamauchi, T.Yamaguchi, K.Nawata et al. // Clin Nutr. - 2010. - Vol. 29. -

№.6. - Р. 761–765.

114

154.Wakabayashi, H. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin / H.Wakabayashi, N.Takakura, K.Yamauchi, Y.Tamura // Clin Vaccine Immunol. - 2006. - Vol.13. - P.239–245.

155.Walker, S.L. Leprosy type 1 (reversal) reactions and their management/ S.L. Walker, D.N. Lockwood // Lepr Rev.- 2008. - Vol. 79. - P.372–386.

156.Ward, P.P. Stimulus-dependent impairment of the neutrophil oxidative burst response in lactoferrin-deficient mice / P.P.Ward, M.Mendoza-Meneses, P.W.Park, O.M. Conneely // Am J Pathol. - 2008. - Vol.172. - P. 1019–29.

157.Welsh, K. J. Influence of Oral Lactoferrin on Mycobacterium tuberculosis

induced immunopathology / K. J. Welsh, S.A. Hwang, S. Boyd et al.//

Tuberculosis (Edinb). - 2011. - Vol. 91. - P.105–113.

158.Weinberg, E.D. Antibiotic properties and applications of lactoferrin/ E.D. Weinberg // Curr Pharm Des. - 2007. - Vol.13. - P. 801–811.

159.Winhofer ,Y. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. / Y.Winhofer, A.Handisurya, A.Tura et al. // Diabetes Care. - 2010. - Vol.33. - №1. - Р.139–143.

160.Wilk, K.M. Lactoferrin modulation of antigen-presenting-cell response to BCG infection/ K.M.Wilk, S.A.Hwang, J.K. Actor // Postepy Hig Med Dosw (Online). - 2007. - Vol. 61. - P.277–282.

161.World Health Organization. Global leprosy situation 2012./ Wkly Epidemiol Record. - 2012. - Vol.34. - P.317–328.

162.Zhou, M. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals / Zhou M., Ma. X, Li. H, Pan X. Tang J., Gao Y.C., Hou X., Lu H., Bao Y., Jia W. // Eur J Endocrinol. - 2009.

115

116